Population pharmacokinetics of exendin‐(9‐39) and clinical dose selection in patients with congenital hyperinsulinism

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2125|84|3|520-532

ISSN: 0306-5251

Source: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.84, Iss.3, 2018-03, pp. : 520-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract